Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis.
about
Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendationsHair relaxer use and risk of uterine leiomyomata in African-American womenA prospective study of dairy intake and risk of uterine leiomyomataAge-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health StudyEtiology and pathogenesis of uterine leiomyomas: a reviewPotential of minimally invasive procedures in the treatment of uterine fibroids: a focus on magnetic resonance-guided focused ultrasound therapy.Magnetic Resonance-Guided High-Intensity Focused Ultrasound (MRgHIFU) Treatment of Symptomatic Uterine Fibroids: An Evidence-Based Analysis.Proton, diffusion-weighted imaging, and sodium (23Na) MRI of uterine leiomyomata after MR-guided high-intensity focused ultrasound: a preliminary study.Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium.MR-guided focused ultrasound (MRgFUS) is effective for the distinct pattern of uterine fibroids seen in African-American women: data from phase III/IV, non-randomized, multicenter clinical trials.5-Hydroxymethylcytosine promotes proliferation of human uterine leiomyoma: a biological link to a new epigenetic modification in benign tumors.Racial/ethnic disparities in environmental endocrine disrupting chemicals and women's reproductive health outcomes: epidemiological examples across the life courseThe fibroid growth study: determinants of therapeutic intervention.Recent Advances in Uterine Fibroid Etiology.Female reproductive disorders: the roles of endocrine-disrupting compounds and developmental timingOne year symptom severity and health-related quality of life changes among Black African patients undergoing uterine fibroid embolisationEvaluation of cardiovascular risk factors in women with uterine leimyoma: is there a link with atherosclerosis?The association between self-reported major life events and the presence of uterine fibroidsUse of dietary phytochemicals to target inflammation, fibrosis, proliferation, and angiogenesis in uterine tissues: promising options for prevention and treatment of uterine fibroids?Genome-wide DNA methylation indicates silencing of tumor suppressor genes in uterine leiomyoma.Racial and ethnic differences in the pathogenesis and clinical manifestations of uterine leiomyoma.Molecular genetics and racial disparities of uterine leiomyomasDoes route of hysterectomy affect outcome in obese and nonobese women?Successful pregnancy following myomectomy for giant uterine fibroid in an infertile womanTotal laparoscopic hysterectomy for uteri over one kilogram.Primary anterior abdominal wall leiomyoma- a diagnostic enigmaReported symptoms before and one year after hysterectomy in African American and white women.Uterine leiomyomas: individualizing the approach to a heterogeneous conditionSurgical Methods for the Treatment of Uterine Fibroids - Risk of Uterine Sarcoma and Problems of Morcellation: Position Paper of the DGGGComparing focused ultrasound and uterine artery embolization for uterine fibroids-rationale and design of the Fibroid Interventions: reducing symptoms today and tomorrow (FIRSTT) trialThe role of progesterone signaling in the pathogenesis of uterine leiomyomaUterine fibroid embolization for symptomatic fibroids: study at a teaching hospital in kenya.Persistent organic pollutants (POPs) and fibroids: results from the ENDO studyEndocrine disrupting chemicals and disease susceptibility.Intake of fruit, vegetables, and carotenoids in relation to risk of uterine leiomyomata.Racial differences in fibroid prevalence and ultrasound findings in asymptomatic young women (18-30 years old): a pilot study.Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study.Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black womenMED12 mutation in patients with hysteromyoma.MED12 exon 2 mutations are common in uterine leiomyomas from South African patients.
P2860
Q24567733-517EA7A8-1773-477B-820C-88F9234B2843Q24631175-48C58FB3-7AB6-42E1-BB53-1384603380F8Q24651884-C3ED0D9C-ABCD-4982-972B-DD7A5A011AE7Q24671052-DD992252-9C79-404B-8B08-AF7EA99BEB0EQ24815132-42194DC7-887C-49C3-BDC8-17010B808E1DQ26775812-E1C098A3-F5B0-4551-BE48-6C6110FEC57AQ26781819-722AE237-D421-47FE-A697-5FE21C1F561AQ30431628-036C10F2-9057-4AC9-8591-AD9C17D62A16Q30432415-2AF51CFA-2F6E-43E2-8188-F110749AA6A7Q30852974-67D3A7D0-293C-4FD1-B11D-CACD88792C79Q33570198-28BBF9D3-36E5-4F84-9B7D-0A159C93607DQ33653351-51C9FDB6-DDBF-4814-93AC-8B3FB0E2C8BAQ33775320-86ED8E4B-B483-4970-B412-1F295DE55919Q33852886-9EAE1490-D568-4CD3-A12A-53BE3C9C8501Q33862059-E6687CA7-054A-4D7F-978D-56445008475BQ33869397-15D7B551-0817-4E11-AA72-A3986E45D885Q33973446-9B1F6B5D-AB62-4726-A364-88B10352C770Q34005487-EC83F5C6-1005-4008-B203-C50CC2722C8DQ34125151-963C62AE-E039-4BA4-8DDE-8DD654A88426Q34200701-48F370E0-6619-45C9-A502-40211BA6D66CQ34223004-02758FA6-F091-45CF-8DA6-1FE0FEDC795DQ34228266-0DC8F6E0-9782-4DC3-AC09-19B803226B40Q34466531-E5575576-BFEA-478B-941D-EBF42383EDBCQ34490755-2E96059A-773F-402E-8BAC-C89FB3F2AD10Q34597053-F80C58FE-D91D-492B-A155-9E81246CD1DFQ34618311-8FE313DF-5524-4671-875D-12EBB1511B11Q35088767-4EA5DEE7-E75A-49B5-9432-666A8A45FA85Q35149373-4557BF6B-C129-4D54-AFC6-1AC101837AF2Q35180929-82BB9DD2-644F-4A9F-A17E-4B28441E7AD7Q35190563-7E3792EA-36E4-4C05-ADAB-4A94358058BDQ35249360-6C8979A3-8147-47D5-BE2B-C0EBE0EA0A64Q35355480-43C95BD7-0E91-4D6C-84B9-BB0F78410578Q35541756-2AA2B275-2B9D-4E8E-8BAE-F91DE41AB149Q35563441-D741A62F-12FB-499D-98AA-5520F4A0D930Q35656460-8706A735-4921-4689-9A92-1FAF88BADDB4Q35737921-620152D8-82DB-4CBB-8500-7B13F997236AQ35741533-6C669D18-9321-4679-978F-597839B3564AQ35741538-EAC60B54-920E-491A-A8E3-BB9F608699BAQ35758997-B3FB4C2F-9B5D-4B63-8F26-CC623AA34D81Q35764426-0C920B71-B7FA-41F4-A0E8-D7E17DAE0ABB
P2860
Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh-hant
name
Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis.
@en
Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis.
@nl
type
label
Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis.
@en
Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis.
@nl
prefLabel
Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis.
@en
Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis.
@nl
P2093
P1476
Uterine leiomyomas. Racial differences in severity, symptoms and age at diagnosis
@en
P2093
Guzinski GM
Kjerulff KH
Langenberg P
Seidman JD
Stolley PD
P304
P577
1996-07-01T00:00:00Z